The Hwang Saga Continues: A Genetic Crossroads Exclusive
By Pete Shanks,
Genetic Crossroads
| 05. 12. 2006
|
|
|
Seoul National University
|
The downfall of South Korean cloning researcher Hwang Woo-Suk, formerly his country's "supreme scientist," continues to play out. Prosecutors have announced that Hwang and his associate Kim Sun-jong will be indicted on charges related to the unethical and illegal procurement of women's eggs. They are still considering criminal charges related to the scientific fraud itself and to embezzlement of government funds. Seoul National University (SNU) has announced that the buildings intended for the ill-fated World Stem Cell Hub, created by Hwang last fall, will now be used for a gene-therapy center focusing on work with adult stem cells.
CGS associate Pete Shanks visited Seoul in April to investigate the scandal further:
Seoul, the capital of South Korea is a huge, modern, vibrant megalopolis. "I didn't like California so much," commented one Korean activist, "Too slow. New York, that's more my speed."
South Korea as a whole is one of the most rapidly urbanizing countries on the planet - more than 80% urban, up from 57% 25 years ago. It has the 9th largest economy in the...
Related Articles
By Carl Zimmer and Marco Hernandez , The New York Times | 07.01.2026
Scientists have long dreamed of discovering the alchemy by which chemicals can be turned into life. On Wednesday, a team at the University of Minnesota announced that it had taken a major step toward that vision.
Blending together dozens of...
By Marisa Flook , BioNews | 06.29.2026
An anti-ageing gene therapy not approved by the US Food and Drug Administration (FDA) is set to be offered by an American company at overseas clinics outside of US jurisdiction.
The treatment, developed by Minicircle from Austin, Texas, uses a...
By Ed Pilkington, The Guardian | 06.12.2026
Desperate US parents paying up to $20,000 a session for a procedure scientists say could be bogus
Autistic children as young as 18 months old are being injected with human stem cells derived from umbilical cords in unapproved, unproven and...
By Tobi Thomas, The Guardian | 06.10.2026
The UK’s stem cell transplant system is potentially putting the lives of blood cancer patients at risk as a result of inadequate infrastructure and a lack of long-term planning, a parliamentary report has found.
A hematopoietic stem cell transplant, often...
